Minipig, pig and rabbit (ocular tox/PK); rcd1 dog for pharmacology; rat and rabbit for rhCNTF DART
“The effect of long-term ITV implantation of NT-501 was evaluated in a 3-part toxicology study in 4–8-month-old minipigs, 4–10-year-old pigs”
✓ VerifiedFDA pharmacology/toxicology review, p. 2Source ↗
Why that species
Disease-relevant animal models support CNTF photoreceptor protection; no explicit species rationale for tox species
“Histopathologic studies in naturally occurring and genetically engineered animal models of photoreceptor dysfunction that phenotypically model retinitis pigmentosa support a role for rhCNTF”
✓ VerifiedFDA pharmacology/toxicology review, p. 6Source ↗
Surrogate molecule
No surrogate cell product; representative NT-501 device used; DART used recombinant human CNTF SC in rat/rabbit
“The nonclinical development program evaluated a product representative of ENCELTO”
✓ VerifiedFDA pharmacology/toxicology review, p. 2Source ↗
Species: general tox
Minipigs and pigs (3-part long-term intravitreal implant toxicology study)
“The effect of long-term ITV implantation of NT-501 was evaluated in a 3-part toxicology study in 4–8-month-old minipigs, 4–10-year-old pigs”
✓ VerifiedFDA pharmacology/toxicology review, p. 2Source ↗
Species: DART
Rat and rabbit (4 DART studies of SC rhCNTF: fertility and teratogenicity)
“Four Developmental and Reproductive Toxicity (DART) studies were conducted in rats and rabbits to establish the risks to fertility and teratogenicity associated with the subcutaneous (SC) administration of high doses of rhCNTF.”
✓ VerifiedFDA pharmacology/toxicology review, p. 2Source ↗
Species: carcinogenicity
Not conducted (not warranted per toxicological risk assessments)
“Studies to evaluate the carcinogenicity/tumorigenicity of ENCELTO were not conducted. These studies are not warranted based on the safety profile described in the provided toxicological risk assessments (TRAs).”
✓ VerifiedFDA pharmacology/toxicology review, p. 3Source ↗
Surrogate used in
No surrogate; a product representative of ENCELTO (NT-501) was tested
“The nonclinical development program evaluated a product representative of ENCELTO”
✓ VerifiedFDA pharmacology/toxicology review, p. 2Source ↗